Does NEDAPLATIN Cause Second primary malignancy? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Second primary malignancy have been filed in association with NEDAPLATIN. This represents 1.1% of all adverse event reports for NEDAPLATIN.
8
Reports of Second primary malignancy with NEDAPLATIN
1.1%
of all NEDAPLATIN reports
5
Deaths
0
Hospitalizations
How Dangerous Is Second primary malignancy From NEDAPLATIN?
Of the 8 reports, 5 (62.5%) resulted in death.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEDAPLATIN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does NEDAPLATIN Cause?
Myelosuppression (272)
White blood cell count decreased (61)
Thrombocytopenia (51)
Off label use (49)
Neutropenia (45)
Neutrophil count decreased (41)
Bone marrow failure (35)
Gastrointestinal disorder (35)
Platelet count decreased (35)
Disease progression (33)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which NEDAPLATIN Alternatives Have Lower Second primary malignancy Risk?
NEDAPLATIN vs NEFAZODONE
NEDAPLATIN vs NEFOPAM
NEDAPLATIN vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG
NEDAPLATIN vs NELARABINE
NEDAPLATIN vs NELFINAVIR